Abstract:Immunoglobulin Y (IgY) is central to our understanding of immunoglobulin evolution. It has links to antibodies from the ancestral IgM to the mucosal IgX and IgA, as well as to mammalian serum IgG and IgE. IgY is found in amphibians, birds and reptiles, and as their most abundant serum antibody, is orthologous to mammalian IgG. However, IgY has the same domain architecture as IgM and IgE, lacking a hinge region and comprising four heavy-chain constant domains. The relationship between IgY and the mucosal antibodies IgX and IgA is discussed herein, in particular the question of how IgA could have contributed to the emergence of IgY. Although IgY does not contain a hinge region, amphibian IgF and duck-billed platypus IgY/O, which are closely related to IgY, do contain this region, as does mammalian IgG, IgA and IgD. A hinge region must therefore have evolved at least three times independently by convergent evolution. In the absence of three-dimensional structural information for the complete Fc fragment of chicken IgY (IgY-Fc), it remains to be discovered whether IgY displays the same conformational properties as IgM and IgE, which exhibit substantial flexibility in their Fc regions. IgY has three characterised Fc receptors, chicken Ig-like receptor AB1 (CHIR-AB1), the chicken yolk sac IgY receptor (FcRY) and Gallus gallus Fc receptor (ggFcR). These receptors bind to IgY at sites that are structurally homologous to mammalian counterparts; IgA/FcαRI for CHIR-AB1, IgG/FcRn for FcRY and IgE/FcϵRI and IgG/FcγR for ggFcR. These resemblances reflect the close evolutionary relationships between IgY and IgA, IgG and IgE. However, the evolutionary distance between birds and mammals allows for the ready generation of IgY antibodies to conserved mammalian proteins for medical and biotechnological applications. Furthermore, the lack of reactivity of IgY with mammalian Fc receptors, and the fact that large quantities of IgY can be made quickly and cheaply in chicken eggs, offers important advantages and considerable potential for IgY in research, diagnostics and therapeutics.

IgY Industries and Markets

Trends in industrialization and commercialization of IgY technology

Adsorption Behaviors of Avian Immunoglobulins and Purification of Immunoglobulin Y from Chicken Serum with Mixed-Mode Resins

Perspectives on IgY Technology

Characterisation and Separation of Infectious Bursal Disease Virus-Like Particles Using Aqueous Two-Phase Systems

Development of IgY Technology: A Historical Perspective

Chicken Egg Yolk Antibodies (IgY-technology): A Review of Progress in Production and Use in Research and Human and Veterinary Medicine

Egg yolk antibodies (IgY) and their applications in human and veterinary health: A review

Comprehensive N-Glycan Profiling of Avian Immunoglobulin Y

IgY: a key isotype in antibody evolution

A review on the application of chicken immunoglobulin Y in aquaculture

From discovery to innovation in animal health: Maturing emerging technologies for industrial development

Proteomic investigation and understanding on IgY purification and product development

Chicken egg yolk antibodies (IgY) as non-antibiotic production enhancers for use in swine production: a review

Applications of IgY in Human Medicine

Potential Use of Single-Chain Fv Proteins for Human and Animal Health

Chimerism of avian IgY‐scFv and truncated IgG‐Fc: A novel strategy in cross‐species antibody generation and enhancement

Recent advances in technology supporting biopharmaceutical production from mammalian cells

The Avian EB66(R) Cell Line, Application to Vaccines, and Therapeutic Protein Production

[The Potential of Avian Cytokines As Immunotherapeutics and Vaccine Adjuvants].

Extraction and Purification of IgY